课题基金 / 基金详情

Real-Time In Vivo Oral Pathology for Clinical Decision Making

Real-Time In Vivo Oral Pathology for Clinical Decision Making
用于临床决策的实时体内口腔病理学
批准号:
462490-2014
负责人:
MacAulay, Calum
金额:
$3.74万
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

MacAulay, Calum的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose to provide new non-invasive optical imaging technology for guiding clinical decisions in the diagnosis and management of oral cancer. This new technology is called optical coherence tomography (OCT) and is analogous to ultrasound imaging except light is used as the imaging signal instead of sound. OCT can provide 3-dimensional images of tissue with resolution approaching histology. Currently, there is no OCT instrument specialized for imaging oral lesions. We propose to build such an instrument that will provide clinicians unprecedented detailed bedside views of oral tissue. Annually, oral cancer is diagnosed in 4100 Canadians and results in 1150 deaths. On the diagnostic front, determining the correct course of treatment for a patient with a suspicious oral lesion requires biopsy and diagnosis by a pathologist. However, the choice of biopsy location is not always obvious, and for larger lesions clinicians often need to take multiple biopsies to try to ensure sampling of the most severe pathology. This incomplete sampling means that the most severe pathology may be overlooked, leading to misdiagnosis. It is hoped that our OCT instrument will enable clinicians to find the most severe pathological site directly, necessitating only a single biopsy while ensuring accurate diagnosis. From the oral cancer management perspective, once oral cancer has been identified, surgical removal is usually the best curative treatment option. The challenge, however, is to determine where are the boundaries of the cancer to ensure precise surgical removal of the entire tumour. We hope that our OCT instrument will provide an additional tool for surgeons to accurately identify the boundary of the tumour so that it can be completely excised to prevent cancer recurrence. If successful, these oral cancer OCT applications will improve patient care and healthcare efficiency by reducing biopsies and ensuring accurate diagnosis, and by preventing cancer recurrence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Real-Time In Vivo Oral Pathology for Clinical Decision Making
  • 批准号:
    462490-2014
  • 项目类别:
    Collaborative Health Research Projects
  • 资助金额:
    $3.37万
  • 财政年份:
    2016
  • 负责人:
    MacAulay, Calum
  • 依托单位:
Real-Time In Vivo Oral Pathology for Clinical Decision Making
  • 批准号:
    462490-2014
  • 项目类别:
    Collaborative Health Research Projects
  • 资助金额:
    $5.62万
  • 财政年份:
    2014
  • 负责人:
    MacAulay, Calum
  • 依托单位:
Co-Registered Autofluorescence and OCT Imaging of the Airways
  • 批准号:
    398894-2011
  • 项目类别:
    Collaborative Health Research Projects
  • 资助金额:
    $4.77万
  • 财政年份:
    2013
  • 负责人:
    MacAulay, Calum
  • 依托单位:
Co-Registered Autofluorescence and OCT Imaging of the Airways
  • 批准号:
    398894-2011
  • 项目类别:
    Collaborative Health Research Projects
  • 资助金额:
    $4.6万
  • 财政年份:
    2012
  • 负责人:
    MacAulay, Calum
  • 依托单位:
国内基金
海外基金
SERS探针诱导TAM重编程调控头颈鳞癌TIME的研究
  • 批准号:
    82360504
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    周学军
  • 依托单位:
华蟾素调节PCSK9介导的胆固醇代谢重塑TIME增效aPD-L1治疗肝癌的作用机制研究
  • 批准号:
    82305023
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王萌
  • 依托单位:
基于MRI的机器学习模型预测直肠癌TIME中胶原蛋白水平及其对免疫T细胞调控作用的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    李文政
  • 依托单位:
结直肠癌TIME多模态分子影像分析结合深度学习实现疗效评估和预后预测
  • 批准号:
    62171167
  • 项目类别:
    面上项目
  • 资助金额:
    57万元
  • 批准年份:
    2021
  • 负责人:
    姜慧杰
  • 依托单位: